BioCatalystWatch
XERSWorkspace / XERS / OverviewCompany library
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. (XERS)

Website

Price
Market cap
Next catalystExpected 2027XP-8121 — Touchstone · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

XP-8121

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

XP-8121

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

Gvoke

PreINDP1P2P3FilingApproved
XP-8121

Upcoming / outlook

  • Timing and evidence

Partner / License out

Approved / commercial

Gvoke

Approved

PreINDP1P2P3FilingApproved
Gvoke

PreINDP1P2P3FilingApproved

Carbonic anhydrase

Approved

PreINDP1P2P3FilingApproved

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

XERS PR & News

PR & News

XERS SEC archive